Show simple item record

dc.contributor.authorBhandari, Nishant
dc.date.accessioned2021-12-15T22:15:42Z
dc.date.available2021-12-15T22:15:42Z
dc.date.issued2021-12-01
dc.identifier.urihttp://hdl.handle.net/20.500.11803/1631
dc.description.abstractMajor Depressive Disorder (MAD) and Generalized Anxiety Disorder (GAD) correlate with earlier mortality rates; those affected die up to eight years earlier than populations without either affective condition (Pratt et al., 2016). There is an increasing need for interventions as trillions of global dollars are lost yearly due to mental health complications (Chisholm et al., 2016). This review evaluates the quality of evidence generated by research to inform treatments for anxiety and depression, and the outcomes of clinical guidelines informed by this research. Most outcome studies and clinical guidelines selected for this review are from 2014 onwards, or as close as possible, in an effort to combat the potential six-year half-life of psychological data (Neimeyer et al., 2014). Findings are aggregated as being MDD specific, GAD specific, MDD-GAD comorbidity specific, or as supporting MDD-GAD relevant themes. Adjusted effect size estimates of psychotherapy suggest psychotherapy is "probably effective" when defined as better than no treatment at all (Cuijpers et al., 2016a, p.245 and p.254). Still, practitioners and researchers should interpret effects cautiously, given the absence of many high-quality studies. Psychotherapy is not responsible for 86% of the variation in outcome studies (see Table 9.1 in Wampold, 2015). In the 14% outcome-influence of psychotherapy, research quality obstructs a conclusive answer to the question of how well outcome measures support current clinical recommendations for treating depression and anxiety. Even if current recommendations are high-quality, and this literature review simply reflects outcomes from practitioners failing to adopt guidelines, improving research quality needs to be a priority in future MDD and GAD studies.en_US
dc.language.isoenen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States
dc.rightsopenAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/
dc.subjectAnxietyen_US
dc.subjectDepressionen_US
dc.subjectGADen_US
dc.subjectMDDen_US
dc.subjectPsychotherapyen_US
dc.subjectCounsellingen_US
dc.subjectMedicationen_US
dc.subjectTreatmenten_US
dc.subjectPharmacologyen_US
dc.subjectOutcomeen_US
dc.subjectEfficacyen_US
dc.subjectComorbidityen_US
dc.subjectEffect sizeen_US
dc.subjectClinical guidelinesen_US
dc.subjectCognitive behavioural therapyen_US
dc.titleThe Utility of Psychotherapy: Meaningful Treatments for Depression and Anxietyen_US
dc.typeCapstoneen_US
thesis.degree.disciplineClinical Mental Health Counselingen_US
thesis.degree.grantorCity University of Seattleen_US
thesis.degree.levelMastersen_US
thesis.degree.nameMaster of Counsellingen_US
cityu.schoolSchool of Health and Social Sciencesen_US
cityu.siteCalgaryen_US
cityu.site.countryCanadaen_US


Files in this item

PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States